Material Flow Varying Means Controlled By Condition Responsive Sensor Patents (Class 604/65)
-
Publication number: 20140018730Abstract: The invention relates to a dosing mechanism for a fluid, comprising an inlet, an outlet, a dosing pipe and two valve groups with an inlet valve and an outlet valve each, wherein the inlet is connected to both inlet valves and the outlet is connected to both outlet valves, wherein the inlet valve of one group is arranged to connect the inlet to a first end of the dosing pipe while the outlet valve of the same group is arranged to connect the outlet to a second end of the dosing pipe, wherein the inlet valve of the other group is arranged to connect the inlet to the second end of the dosing pipe while the outlet valve of the same group is arranged to connect the outlet to the first end of the dosing pipe, wherein control means are arranged to open only the valves of one group at a time thereby allowing the fluid to flow from the inlet through the dosing pipe to the outlet, wherein a dosing object is arranged in the dosing pipe in a manner to be translated from one end towards the other by the fluid, wherein a dType: ApplicationFiled: March 28, 2012Publication date: January 16, 2014Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBHInventor: Stephan Müller-Pathle
-
Patent number: 8628493Abstract: A flexible spirally-rolled polymer microtube for in vivo monitoring and treatment of brain injuries; the tube integrally comprising one or more microsensors and one or more microchannels, wherein the microsensors monitor one or more parameters and the microchannels are capable of delivering substances to the brain, removing substances from the brain, or both.Type: GrantFiled: June 3, 2009Date of Patent: January 14, 2014Assignee: The Feinstein Institute for Medical ResearchInventors: Chong H. Ahn, Raj K. Narayan, Chunyan Li
-
Patent number: 8622979Abstract: An infusion pump, including: a microprocessor; a drip chamber; a drip tube with an end in the drip chamber; and an illumination system: with a light source for transmitting light through the drip chamber to a drop of fluid suspended from the drip tube; and for controlling illumination properties of the light transmitted to the drop. The pump includes an optical system for: receiving light transmitted through the drop; and transmitting, to the microprocessor, data regarding the received light. The microprocessor: generates, using the data, an image of the drop; locates, using the image, an outer edge of the drop to define a boundary of the drop; integrates an area enclosed by the boundary; and calculates a volume of revolution for the drop with respect to an axis for the drop that intersects the end of the drip tube, assuming symmetry of the drop with respect to the axis.Type: GrantFiled: October 19, 2010Date of Patent: January 7, 2014Assignees: Baxter Healthcare S.A., Baxter International Inc.Inventors: Roger L. Hungerford, Tuan Bui
-
Patent number: 8622988Abstract: Methods, system and devices for monitoring a closed loop control operation including signal levels received from an analyte sensor at a predetermined frequency, determining a variation in the monitored analyte level, determining a medication delivery rate adjustment frequency to deliver a medication based on the determined variation in the monitored analyte level, and adjusting the closed loop control operation to modify the medication delivery rate frequency are provided.Type: GrantFiled: August 31, 2008Date of Patent: January 7, 2014Assignee: Abbott Diabetes Care Inc.Inventor: Gary Hayter
-
Patent number: 8608642Abstract: An environmentally sensitive hydrogel material swells or collapses in response to a parameter such as pH level associated with consumption of food by a patient. This swelling or collapsing is harnessed to treat morbid obesity or some other condition of the patient. The swelling or collapsing of the hydrogel may be used to tighten a gastric band or gastric valve when the patient starts eating; then loosen the band or valve when the patient is between meals. The swelling or collapsing of the hydrogel may also be used to increase the size of a space occupying device in the patient's stomach when the patient starts eating; then decrease the size of the space occupying device when the patient is between meals. The swelling or collapsing of the hydrogel may also be used to selectively restrict the absorption of nutrients within a patient's gastrointestinal tract, such as in the duodenum.Type: GrantFiled: February 25, 2010Date of Patent: December 17, 2013Assignee: Ethicon Endo-Surgery, Inc.Inventors: Janna M. Burrell, Randal T. Byrum, Robert Louis Koch, Jr., Larry D. Pool, Christopher W. Widenhouse
-
Patent number: 8612055Abstract: A fluid delivery system comprises a pump configured to deliver a therapeutic agent to a patient, a memory storing a therapy program defining the delivery of the therapeutic agent to the patient by the pump and a default infusion schedule based on the therapy program, and a processor configured to control the pump to deliver the therapeutic agent to the patient according to the therapy program, to determine an error condition that prevents the pump from continuing to deliver therapy according to the therapy program, and, upon determination of the error condition, to control the pump to deliver the therapeutic agent to the patient according to the default infusion schedule.Type: GrantFiled: April 16, 2010Date of Patent: December 17, 2013Assignee: Medtronic, Inc.Inventors: Irfan Z. Ali, Steven M. Goetz, David C. Ullestad, Emem D. Akpan, Mark D. Salzwedel, Jiaying Shen
-
Patent number: 8603057Abstract: A system and method are disclosed for automatically limiting the drainage of a bodily fluid such as cerebrospinal fluid (CSF) from a patient into a collection chamber. The collection chamber includes a vent having an hydrophobic filter for the passage of air to facilitate the movement of CSF yet to maintain a closed system. The system includes a buoyant float hingedly connected with the top of the collection chamber in one embodiment. When fluid rises in the collection chamber to a predetermined volume, buoyant force raises the float and causes a seal plug mounted on top of the float to seal one of an inflow port or a vent port. The float is limited to pivoting movement in one plane and to a certain angle within that plane. The system and method avoid overdrainage of CSF from the patient and overfilling of the collection chamber.Type: GrantFiled: July 16, 2012Date of Patent: December 10, 2013Assignees: Integra LifeSciences Corporation, The Regents of the University of CaliforniaInventors: Brian Hoffman, Michael McDermott, William R. Chang, Eric Scott Clasen
-
Patent number: 8597273Abstract: A system for operating a semi-closed loop and/or a closed loop resuscitation of a burn patient in view of patient information and other physiological data gathered by the system. The system in at least one embodiment includes an urine sensor, an infusion pump and a processor that controls the operation of the infusion pump at least in part from a signal received from the urine sensor.Type: GrantFiled: April 3, 2012Date of Patent: December 3, 2013Assignee: The United States of America as Represented by the Secretary of the ArmyInventors: Jose Salinas, George C. Kramer, Guy A. Drew
-
Patent number: 8591464Abstract: A system and a method for distending a body tissue cavity of a subject by continuous flow irrigation by using two positive displacement pumps, such as peristaltic pumps, one pump on the inflow side and another pump on the outflow side, such that the amplitude of the pressure pulsations created by the positive displacement pumps inside the tissue cavity is substantially dampened to almost negligible levels. The present invention also provides a method of reducing the frequency of the said pressure pulsations. The present invention also provides a method for accurately determining the rate of fluid loss, into the subject's body system, during any endoscopic procedure without utilizing any deficit weight or fluid volume calculation, the same being accomplished by using two fluid flow rate sensors.Type: GrantFiled: August 26, 2005Date of Patent: November 26, 2013Inventors: Atul Kumar, Alka Kumar
-
Patent number: 8591454Abstract: A system for administering a therapeutic agent to a subject; for administering a first pharmaceutically-acceptable taggant to the subject at least substantially concurrent with the therapeutic agent, the first pharmaceutically-acceptable taggant having a pharmacokinetic profile; and for administering a second pharmaceutically-acceptable taggant to the subject with the first pharmaceutically-acceptable taggant, the second pharmaceutically-acceptable taggant having a pharmacokinetic profile different from the pharmacokinetic profile of the first pharmaceutically-acceptable taggant.Type: GrantFiled: November 10, 2008Date of Patent: November 26, 2013Assignee: The Invention Science Fund I, LLCInventors: Roderick A. Hyde, Muriel Y. Ishikawa, Jordin T. Kare, Eric C. Leuthardt, Dennis J. Rivet, Lowell L. Wood, Jr., Victoria Y. H. Wood
-
Patent number: 8585637Abstract: A closed-loop method for insulin infusion overnight uses a model predictive control algorithm (“MPC”). Used with the MPC is a glucose measurement error model which was derived from actual glucose sensor error data. That sensor error data included both a sensor artifacts component, including dropouts, and a persistent error component, including calibration error, all of which was obtained experimentally from living subjects. The MPC algorithm advised on insulin infusion every fifteen minutes. Sensor glucose input to the MPC was obtained by combining model-calculated, noise-free interstitial glucose with experimentally-derived transient and persistent sensor artifacts associated with the FreeStyle Navigator® Continuous Glucose Monitor System (“FSN”).Type: GrantFiled: September 22, 2011Date of Patent: November 19, 2013Assignees: Abbott Diabetes Care Inc., Cambridge Enterprise LimitedInventors: Malgorzata E. Wilinska, Erwin S. Budiman, Gary A. Hayter, Marc B. Taub, Roman Hovorka
-
Patent number: 8585675Abstract: A method for providing decision-assist to medical staff resuscitating a burn patient includes receiving patient information, calculating an infusion rate, outputting the infusion rate, obtaining a urinary output, calculating a new infusion rate using infusion rate model based constants, and outputting the new infusion rate. In some embodiments, the method includes notifying medical staff when problems arise, displaying information regarding the resuscitation, and setting limits regarding the infusion rates.Type: GrantFiled: January 29, 2011Date of Patent: November 19, 2013Assignee: The United States of America as Represented by the Secretary of the ArmyInventors: Jose Salinas, George C. Kramer, Leopoldo C. Cancio, Kevin Chung, Elizabeth Mann, Steven E. Wolf, Guy A. Drew
-
Patent number: 8579853Abstract: Medical devices having restrictive access, and methods thereof are provided.Type: GrantFiled: October 31, 2006Date of Patent: November 12, 2013Assignee: Abbott Diabetes Care Inc.Inventors: Christopher V. Reggiardo, Namvar Kiaie, James Thomson
-
Patent number: 8568349Abstract: An injection device for injecting a fluid into an organism, in particular a human or animal body, which can comprise a fluid providing section including a container for storing the fluid and a supply means for supplying the fluid. The fluid injecting section for injecting the fluid provided by the fluid providing section into the organism includes a catheter means and is characterized by the fluid injecting section being provided with a pressure recognition arrangement which can be located close to and/or in the catheter means for detecting a pressure increase and/or a pressure loss.Type: GrantFiled: February 25, 2011Date of Patent: October 29, 2013Assignee: Roche Diagnostics International AGInventor: Oliver Shergold
-
Publication number: 20130281969Abstract: A controlled release nanoparticulate matter delivery system includes a plurality of thermoresponsive modules containing a respective nanoparticulate matter. Each thermoresponsive module is selectively operable in at least one of a heating mode that releases the nanoparticulate matter and a cooling mode that inhibits release of the nanoparticulate matter. A control module is in electrical communication with the plurality of thermoresponsive modules. The control module is configured to determine a temperature of each thermoresponsive module and to select the at least one heating mode and cooling mode based on the temperature. The heating and cooling mode may be selected in response to a desired dosing profile and/or a biometric condition.Type: ApplicationFiled: March 22, 2013Publication date: October 24, 2013Inventors: Letia M. Blanco, Kyle C. Godfrey, Christopher A. Grace, Christopher B. Alberts, Andrew E. Patin, Panayiotis S. Shiakolas, Pranesh B. Aswath
-
Patent number: 8556846Abstract: A blood volume control method has been developed including: monitoring a condition of a patient (such as hematocrit (Hct)), wherein the condition is indicative of blood volume in the patient; automatically determining that the condition indicates a low blood volume in the patient; automatically infusing an infusion solution into the patient in response to the determination of a low blood volume, and automatically adjusting the infusion to maintain the monitored condition at a predetermined value.Type: GrantFiled: July 27, 2006Date of Patent: October 15, 2013Assignee: Gambro UF Solutions, Inc.Inventors: John J. O'Mahony, Paul A. Sobotka, Edward G. Rychlick
-
Patent number: 8551039Abstract: Devices, systems and methods are provided for drug delivery and the monitoring thereof.Type: GrantFiled: March 30, 2011Date of Patent: October 8, 2013Inventors: Eric D Veit, Adam Bylund, Barry Weber, Peter Luther, Joseph McCluskey, Jean Bidegainberry
-
Patent number: 8554317Abstract: A method of treating a patient with a microneedle array having an active agent disposed on at least a portion of one or more of the microneedles, wherein the array with active agent is characterized by a first optical response when probed with a selected incident light spectrum. The array with active agent is applied to a skin surface, optionally allowed to remain on the skin surface for a specified time, and removed. The used array is probed with the selected incident light spectrum, a second optical response is sensed, and the difference between the first optical response and the second optical response is determined and compared to a predetermined threshold value.Type: GrantFiled: November 16, 2006Date of Patent: October 8, 2013Assignee: 3M Innovative Properties CompanyInventor: Daniel C. Duan
-
Patent number: 8551037Abstract: One implementation provides a method to provide injection procedure information in an injection system. In this implementation, the method includes displaying a plurality of different injection procedure options in a user interface of said system, wherein said plurality of different injection procedure options including a cardiac procedure option and a non-cardiac procedure option. The method further includes receiving a user selection of an injection procedure from said displayed plurality of difference injection procedure options, processing a default set of injection parameters based upon said selected injection procedure, and displaying said default set of injection parameters within the user interface of the system prior to an injection.Type: GrantFiled: September 9, 2011Date of Patent: October 8, 2013Assignee: ACIST Medical Systems, Inc.Inventors: Todd Suchecki, Deborah Jean Brown
-
Publication number: 20130261539Abstract: A capacitive fluid level sensing arrangement for use in a medical device is provided. The arrangement includes at least one pair of conductive plates configured to increase and decrease the amount of electric charge stored in relation to the level of fluid within a fluid maintaining device, such as a reservoir. The conductive plates are electrically connected to a medical device and are configured to measure the charge stored between the plates and thus sense the fluid level. The electric circuit may communicate the measurement to an instrument host arrangement for operating a pump configured to remove fluid from the reservoir and move the fluid to a collector when the level exceeds a preset upper level amount. The instrument host arrangement may stop operating the pump when the fluid level is reduced to a preset lower level amount.Type: ApplicationFiled: May 22, 2013Publication date: October 3, 2013Inventor: David A. King
-
Publication number: 20130261372Abstract: Devices, methods, and compositions are described that includes an implantable device including one or more compartments. One or more pharmaceutically effective compounds stabilized in a sugar glass composition, at least one of the one or more stabilized pharmaceutically effective compounds in the sugar glass composition enclosed within the one or more compartments; and one or more reservoirs configured to provide access for one or more release agents to an interior of the sugar glass composition, wherein the one or more reservoirs are configured to controllably dispense the one or more release agents to disrupt the sugar glass composition from the interior of the sugar glass composition.Type: ApplicationFiled: March 30, 2012Publication date: October 3, 2013Inventors: Roderick A. Hyde, Jordin T. Kare, Gary L. McKnight, Nathan P. Myhrvold, Tony Pan, Elizabeth A. Sweeney, Lowell L. Wood, JR.
-
Patent number: 8545483Abstract: Systems and methods are provided which enable communications to be initiated locally relative to an individual's developing physiological condition and remotely as the condition requires. Physiological sensors and associated medical delivery systems can be coupled to a unit wearable by an individual which can provide various audible or visual outputs and one or more manual inputs indicative of the individual's condition. A global positioning unit can be incorporated so that condition information as well as location information can automatically be provided, wirelessly, to a remote monitoring system for follow up as needed.Type: GrantFiled: March 12, 2007Date of Patent: October 1, 2013Assignee: Honeywell International Inc.Inventors: Jackie A. Schwabe, Chris Budish
-
Patent number: 8545440Abstract: Devices and systems for injecting fluids and/or other materials into a targeted anatomical location, in particular, a joint or intra-articular space, include a handpiece assembly having a needle extending from its distal end, a fluid delivery module comprising a cassette and a fluid transfer device. A conduit is generally configured to place the fluid delivery module in fluid communication with the handpiece assembly. Medicaments, formulations and/or other fluids or materials contained within vials that are secured to a cassette or other portion of the fluid delivery module can be selectively delivered into an anatomy through a needle located at the distal end of the handpiece assembly. In some embodiments, ultrasound or other imaging technologies can be used to locate a joint or other targeted anatomical location.Type: GrantFiled: June 24, 2010Date of Patent: October 1, 2013Assignee: Carticept Medical, Inc.Inventors: Timothy Patrick, Richard Knostman, Michael Axelrod, Carribeth Ramey
-
Publication number: 20130253422Abstract: A fluidic media detection system for detecting a presence of fluidic media includes a first housing portion adapted to be carried by a user; a second housing portion configured to be selectively operatively engaged with and disengaged from the first housing portion, the second housing portion for supporting a reservoir having an interior volume for containing fluidic media; a fluid conduit supported by one of the first housing portion and the second housing portion for providing fluid communication between the reservoir and the user when the first housing portion and the second housing portion are operatively engaged; and at least one interactive element, positioned near a portion of the fluid conduit, that interacts with the fluidic media when the fluidic media is present in the fluid conduit.Type: ApplicationFiled: May 22, 2013Publication date: September 26, 2013Applicant: Medtronic MiniMed, Inc.Inventors: Ian B. Hanson, Paul F. Bente, IV
-
Patent number: 8540664Abstract: The subject matter disclosed herein provides a response to a dose of a substance and/or controls the administration of the dose. In one aspect, there is provided a system. The system may include a processor and at least one memory configured to provide a response determinator. The response determinator may receive therapeutic and wellness data. Moreover, the response determinator may determine a response based on the received therapeutic and wellness data. The response may represent a reaction to a substance integrated with an ingestible event marker. The determined response may be provided to, for example, a therapy controller. Related systems, methods, and articles of manufacture are also described.Type: GrantFiled: March 24, 2010Date of Patent: September 24, 2013Assignee: Proteus Digital Health, Inc.Inventors: Timothy Robertson, Yashar Behzadi
-
Patent number: 8535261Abstract: A system for administering a therapeutic agent to a subject; for administering a first pharmaceutically-acceptable taggant to the subject at least substantially concurrent with the therapeutic agent, the first pharmaceutically-acceptable taggant having a pharmacokinetic profile; and for administering a second pharmaceutically-acceptable taggant to the subject with the first pharmaceutically-acceptable taggant, the second pharmaceutically-acceptable taggant having a pharmacokinetic profile different from the pharmacokinetic profile of the first pharmaceutically-acceptable taggant.Type: GrantFiled: November 10, 2008Date of Patent: September 17, 2013Assignee: The Invention Science Fund I, LLCInventors: Roderick A. Hyde, Muriel Y. Ishikawa, Jordin T. Kare, Eric C. Leuthardt, Dennis J. Rivet, Lowell L. Wood, Jr., Victoria Y. H. Wood
-
Patent number: 8535522Abstract: The present invention is directed to a dialysis system with a disconnection monitor for determining if a blood line connection to a patient has been disconnected. It includes a blood circuit in fluid communication with a patient and a dialysis circuit, a pressure transducer for generating a signal indicative of a pulse signal in the blood circuit, a cardiac reference signal generator for generating a signal indicative of the patient's pulse and a disconnection monitor. The disconnection monitor includes a pressure transducer data receiver for receiving the signal indicative of the pulse signal in the blood circuit, a cardiac reference signal receiver for receiving the signal indicative of the patient's pulse, and a processor for cross-correlating the signal indicative of the pulse signal in the blood circuit and the signal indicative of the patient's pulse to generate data indicative of a disconnection of the blood line connection to the patient.Type: GrantFiled: February 12, 2010Date of Patent: September 17, 2013Assignee: Fresenius Medical Care Holdings, Inc.Inventors: Barry Neil Fulkerson, James R. Braig
-
Patent number: 8529486Abstract: A hemofiltration system and method for pumping blood from a patient's blood stream into an access line, introducing an anticoagulant solution into the pumped blood, filtering the pumped blood and delivering it to a return line, introducing a substitution fluid into the pumped blood, introducing a calcium and magnesium solution into the blood traveling through the return line, and returning the blood back to the patient's blood stream.Type: GrantFiled: January 26, 2012Date of Patent: September 10, 2013Assignees: Baxter International Inc., Baxter Healthcare S.A.Inventor: Jean-Michel Lannoy
-
System and method for pseudo-continuous measurement of metabolite concentrations in a mammalian body
Patent number: 8524154Abstract: A metabolite monitoring system comprising a microdialysis probe including a semi-permeable membrane and a probe flow path passing from an inlet through a sensing volume adjacent to said semi-permeable membrane to an outlet, a fluid delivery device for delivering dialysate to said inlet; and a metabolite monitoring system associated with said outlet for monitoring a concentration of at least one metabolite in said dialysate from said microdialysis probe, wherein said fluid delivery device is configured to deliver a pulsed flow of said dialysate to said inlet.Type: GrantFiled: November 8, 2007Date of Patent: September 3, 2013Assignee: G-Sense Ltd.Inventors: Avraham Shekalim, Noam Peleg -
Publication number: 20130226137Abstract: A system for delivering or withdrawing a fluid to or from the body of a patient in a manner that permits delivery to be controlled based upon feedback from the patient, the system including a syringe assembly providing a syringe operably coupled to one or more sensors adapted to determine one or more corresponding parameters associated with fluid delivery and/or withdrawal, and a monitor adapted to be communicably associated with the one or more sensors of the syringe assembly, and optionally with other sensors or inputs providing additional parameters as well, the monitor comprising one or more read out mechanisms either directly or indirectly corresponding to the one or more fluid delivery/withdrawal parameters, and optionally with one or more of the additional parameters as well.Type: ApplicationFiled: November 5, 2012Publication date: August 29, 2013Applicant: RELOX MEDICAL, LLCInventor: Relox Medical, LLC
-
Patent number: 8518025Abstract: A system is provided for clearing modes of operation on a multicomponent medical instrument with a basic instrument (1) and at least one connectable accessory instrument (4) for the basic instrument (1). The accessory instrument (4) is equipped with a wireless, readable data memory (2) for modes of operation of the medical instrument and the basic instrument (1) has a reading unit (3) for the data memory (2). The reading unit (3), when the accessory instrument (4) is connected, reaches a sending/receiving range for reading out the data.Type: GrantFiled: June 16, 2006Date of Patent: August 27, 2013Assignee: Dräger Medical GmbHInventors: Olaf Schermeier, Marita Kalfke, Andreas Otto, Gerd Wotha
-
Patent number: 8517987Abstract: A modular external infusion device that controls the rate a fluid is infused into an individual's body, which includes a first module and a second module. More particularly, the first module may be a pumping module that delivers a fluid, such as a medication, to a patient while the second module may be a programming module that allows a user to select pump flow commands. The second module is removably attachable to the first module.Type: GrantFiled: February 16, 2012Date of Patent: August 27, 2013Assignee: Medtronic Minimed, Inc.Inventors: Emilian Istoc, Himanshu Patel
-
Patent number: 8512273Abstract: A method, a system, and a computer program for calibration of sensitivity of a subject to a drug. The subject is delivered with the drug at a delivery rate and a signal responsive to the drug is measured from the subject. When determining the sensitivity of the subject to the drug in question, a change in the delivery rate of the drug is initiated. The change in the delivery rate causes a small change in the signal responsive to the drug. The change in the measured signal caused by the drug delivery rate change is detected, and the sensitivity of the patient is determined.Type: GrantFiled: February 28, 2007Date of Patent: August 20, 2013Assignee: General Electric CompanyInventors: Tor Borje Rantala, Morkku Paloheimo
-
Patent number: 8512276Abstract: An infusion system includes an infusion device and a sensing device. The infusion system may further include a characteristic determining device. The infusion device also includes a communication system for transmitting to and receiving communications from the sensing device or a computer. The sensing device may sense an analyte of a bodily fluid of the user. The analyte may be calibrated using data from the infusion device and from a characteristic determining device. The system may be set up to automatically call for assistance when analytes reach a certain level.Type: GrantFiled: June 14, 2004Date of Patent: August 20, 2013Assignee: Medtronic Minimed, Inc.Inventors: Cary D. Talbot, Mark C. Estes, John J. Mastrototaro, Sheldon B. Moberg, John C. Mueller, Jr., “Mike” Charles Vallet Tolle, Gary L. Williams
-
Patent number: 8504179Abstract: A method of programming an ambulatory infusion pump from a computer. The ambulatory infusion pump is programmed to execute a delivery program, and the delivery program is driven by operating parameters. The method comprises generating a table on the computer, the table containing a row, the row having a plurality of cells, each cell in the row relating to a different operating parameter for the delivery program; entering an operating parameter into at least one of the cells; and downloading the operating parameters into the pump.Type: GrantFiled: February 28, 2002Date of Patent: August 6, 2013Assignee: Smiths Medical ASD, Inc.Inventor: Michael L. Blomquist
-
Patent number: 8500705Abstract: The present invention relates to the analysis apparatus capable of collecting the body fluid such as urine or blood, for embodiment urination and measuring or calculating the specific constituent from the collected body urine, and the apparatus for collecting body fluid capable of using by connecting to the analysis apparatus and its related article, in which the apparatus for collecting and analyzing for the body fluid of a patient consists of the body fluid collecting part and the collecting part case, the apparatus for collecting body fluid consists of the body fluid collecting part, the total tube and adapter, the collecting part is constructed with the absorbing tube, the sensor tube, the cleansing tube and the passage and is attachable/detachable connected to the collecting part, a diaper and pants exclusive for a patient are provided as the related article such that it is convenient to possess and has effects in the urination having no relations to the intention of a patient or in case of unable to useType: GrantFiled: July 2, 2007Date of Patent: August 6, 2013Assignee: Kyungin Metal Industry Co., Ltd.Inventor: Kyoung Hun Kim
-
Patent number: 8502662Abstract: The invention, in general, relates to communications systems for medical devices. In particular, the present invention is directed toward a communications routine for a medical infusion devices and a remote control unit that includes data elements within the transmissions that indicate the operating status of the infusion device.Type: GrantFiled: June 30, 2009Date of Patent: August 6, 2013Assignee: Animas CorporationInventors: David Pohlman, Krzysztof Brukalo
-
Patent number: 8496612Abstract: A syringe adapter includes an adapter body having a first connecting portion that may be received into a power injector unit used to deliver contrast media. The adapter also includes a second connecting portion configured to receive the rearward end of an associated syringe. The adapter includes means for encoding information about the associated syringe that may be communicated to the power injector unit through one or more sensors. The means for encoding information may include a mechanism that moves linearly laterally back and forth to activate an actuator used to convey the encoded information. In particular, the action of installing the adapter may be decoupled from the action of encoding information.Type: GrantFiled: February 9, 2010Date of Patent: July 30, 2013Assignee: Coeur, Inc.Inventor: J. Michael Cude
-
Publication number: 20130190682Abstract: A system for controlling an environment of a patient undergoing an surgical procedure is provided. The system includes a conduit configured to channel fluids towards the patient, a sensor configured to measure at least one operating parameter of the fluid being channeled to the patient, an effector configured to change the operating parameter of the fluid, and a controller configured to selectively activate the effector based on a signal received from the sensor.Type: ApplicationFiled: July 26, 2012Publication date: July 25, 2013Inventors: Peter M. Bonutti, Justin Beyers
-
Patent number: 8491523Abstract: Methods of conducting thrombectomy procedures and deploying a thrombectomy catheter are disclosed. A thrombectomy procedure is conducted with a thrombectomy catheter deployment system. A drive unit configured to operate an infusion pump is provided. The drive unit is operable according to one or more operating modes. A preconnected and consolidated pump and catheter assembly configured for loading in the drive unit is also provided. The assembly is separate from the drive unit prior to loading. The infusion pump and a catheter of the assembly are in communication prior to loading. The assembly provides one or more digital instructions to the drive unit. The drive unit is operable according to the one or more operating modes referenced by the one or more digital instructions. The assembly is loaded into the drive unit, and the drive unit is engaged to the infusion pump for operation of the infusion pump.Type: GrantFiled: May 2, 2011Date of Patent: July 23, 2013Assignee: Medrad, Inc.Inventors: Eric Joel Thor, Michael John Bonnette, Nicole Jaye Aasen, Martyn Stuart Abbott, Douglas James Ball, Walter Charles Croll, David Charles Cummings, James Fredrick Karpinski, Daniel Joseph Kneip, Jeffrey William Rogers, Ernest Ralph Scherger, III, John Lloyd Teschendorf, Stephen Earl Weisel, David Woodruff West
-
Patent number: 8491184Abstract: A sensor apparatus and sensor apparatus system for use in conjunction with a cassette, including a disposable or replaceable cassette. In some embodiments, the cassette includes a thermal well for permitting the sensing of various properties of a subject media. The thermal well includes a hollow housing of a thermally conductive material. In other embodiments, the cassette includes sensor leads for sensing of various properties of a subject media. The thermal well has an inner surface shaped so as to form a mating relationship with a sensing probe. The mating thermally couples the inner surface with a sensing probe. In some embodiments, the thermal well is located on a disposable portion and the sensing probe on a reusable portion.Type: GrantFiled: February 27, 2008Date of Patent: July 23, 2013Assignee: DEKA Products Limited PartnershipInventors: Dean Kamen, N. Christopher Perry, Jason A. Demers, Brian Tracey, Arun D. Chawan, Kevin L. Grant
-
Patent number: 8493224Abstract: A system for clamping a flexible tube containing medical fluids includes a cable assembly coupled to a remote driver and a slidable clamp that imparts a clamping force to the flexible tube. An electrical continuity detector is included to measure the wear of an internal insulating layer of the cable between a sliding inner wire and a cable casing member. An indication of the wear to the cable is generated in response to a comparison of the electrical integrity of the insulating layer with a threshold. The wear indication enables the cable to be repaired or replaced prior to a malfunction of the overall tube clamp system.Type: GrantFiled: March 7, 2011Date of Patent: July 23, 2013Assignee: Terumo Cardiovascular Systems Corp.Inventor: Zachary A. Coon
-
Patent number: 8486005Abstract: Systems and methods for detecting an occlusion in a fluid delivery device are disclosed. The system includes a fluid delivery tube, an occlusion detection sensor configured to be coupled to the fluid delivery tube and further configured to detect occlusion within the fluid delivery tube. The fluid delivery tube includes an occlusion detection portion. The occlusion detection sensor is further configured to detect alteration of a shape of the occlusion detection portion when at least one condition occurs within the fluid delivery tube.Type: GrantFiled: January 10, 2011Date of Patent: July 16, 2013Assignee: Medingo Ltd.Inventors: Ofer Yodfat, Gavriel J. Iddan, Gil Senesh
-
Publication number: 20130178791Abstract: The present invention generally relates to radio-enabled devices for detection and remedy of biological and chemical warfare attack. More particularly, this invention relates to an on-body apparatus that provides a means of treatment which is innocuous to the wearer, but capable of injecting antidotes within seconds and preferably also combines multiple means of sensing chemical and biological agents as well as monitoring user's physiological response to the antidotes thereby to enable tailored and continuous infusion of antidotes while minimizing the side effect of the antidotes themselves. A key embodiment of this invention is the incorporation of an electronically-controlled needle or cannula that will deploy only when commanded to. When not deployed, the device sits inertly against the patient's skin, affixed by adhesive and or elastic materials.Type: ApplicationFiled: January 9, 2012Publication date: July 11, 2013Inventor: Jonathan C. Javitt
-
Patent number: 8480616Abstract: The subject matter disclosed herein provides a response to a dose of a substance and/or controls the administration of the dose. In one aspect, there is provided a system. The system may include a processor and at least one memory configured to provide a response determinator. The response determinator may receive therapeutic and wellness data. Moreover, the response determinator may determine a response based on the received therapeutic and wellness data. The response may represent a reaction to a substance integrated with an ingestible event marker. The determined response may be provided to, for example, a therapy controller. Related systems, methods, and articles of manufacture are also described.Type: GrantFiled: March 24, 2010Date of Patent: July 9, 2013Assignee: Proteus Digital Health, Inc.Inventors: Timothy Robertson, Yashar Behzadi
-
Patent number: 8480655Abstract: A drug infusion system capable of delivering a fluid medication to a patient under direction of a medical professional continually at a basal rate and at an interval rate in each of a plurality of time slots over a specified period of time. The total dose of the fluid medication to be delivered to the patient over the period of time based on the basal rate and the interval rate for each of the plurality of time slots is determined, compared the total dose against a maximum dose. The basal rate is adjusted, if necessary, so that the total dose does not exceed the maximum dose.Type: GrantFiled: June 21, 2011Date of Patent: July 9, 2013Assignee: Medtronic, Inc.Inventors: Keith E. Jasperson, Thomas J. Valine, Frederic J. R. Wahlquist
-
Patent number: 8469920Abstract: A disposable, wearable, self-contained insulin dispensing device includes a housing and an insulin source in the housing that is connected to a catheter for injecting insulin into a user.Type: GrantFiled: June 18, 2010Date of Patent: June 25, 2013Assignee: Asante Solutions, Inc.Inventors: Morten Mernoe, Michael Lyngsie
-
Publication number: 20130158472Abstract: The present invention is directed to a subcutaneous controlled delivery device that provides for a refillable reservoir port, a release mechanism and tubing that operably connects the reservoir port to the release mechanism. Such a device is capable of being implanted under the dermis of the skin and allows for the controlled release of drugs, biological agents or therapeutic agents to a target site of interest in the body for treatment.Type: ApplicationFiled: December 17, 2012Publication date: June 20, 2013Inventor: Jaishankar Raman
-
Publication number: 20130150823Abstract: The invention relates to a method and apparatus for providing hydration fluids. The invention allows for a ‘background’ rate of providing a hydration fluid to be automatically supplied by an apparatus to a patient, for example intravenously, and for the patient to receive an extra amount of hydration fluid, or ‘bolus dose’, to be provided when the patient sends a signal to the apparatus. In preferred embodiments the background supply rate, the volume and rate of supply of the bolus dose and the maximum extra volume that can be provided as bolus doses in a given time can be set, for example, by a nurse.Type: ApplicationFiled: January 21, 2011Publication date: June 13, 2013Inventors: Hugh E. Montgomery, Michael Mythen, Anthony Thorne
-
Patent number: 8460231Abstract: Systems and methods for integrating a continuous glucose sensor, including a receiver, a medicament delivery device, and optionally a single point glucose monitor are provided. Manual integrations provide for a physical association between the devices wherein a user (for example, patient or doctor) manually selects the amount, type, and/or time of delivery. Semi-automated integration of the devices includes integrations wherein an operable connection between the integrated components aids the user (for example, patient or doctor) in selecting, inputting, calculating, or validating the amount, type, or time of medicament delivery of glucose values, for example, by transmitting data to another component and thereby reducing the amount of user input required. Automated integration between the devices includes integrations wherein an operable connection between the integrated components provides for full control of the system without required user interaction.Type: GrantFiled: July 11, 2011Date of Patent: June 11, 2013Assignee: DexCom, Inc.Inventors: James H. Brauker, Mark A. Tapsak, Sean T. Saint, Apurv U. Kamath, Paul V. Neale, Peter C. Simpson, Michael Robert Mensinger, Dubravka Markovic